Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.

Journal of computational biology : a journal of computational molecular cell biology - 1 Oct 2020

Shu Yongqian, Wu Xiaohong, Shen Jia, Luo Dongdong, Li Xiang, Wang Hailong, Tang Yuanhua Tom

Abstract excerpt

FD-180 and FD-600 are two next-generation sequencing panels developed by First Dimension Biosciences Co. for detecting mutations in cancer tissues and providing therapeutics guidance in precision medicine applications. FD-180 includes the coding exons of about 180 genes, including all the known drug target genes and some important driver genes; whereas FD-600 includes the coding exons of 578 cancer driver genes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to High-Throughput Nucleotide Sequencing

Share to Immunotherapy

Share to INDEL Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 32311294
DOI: 10.1089/cmb.2019.0055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.PMID 32311294Read ↗

Next-Generation Sequencing in Oncology in the Era of Precision Medicine.Semantic proximity Read ↗

Validation of a targeted sequencing panel with automatic analysis system for clinical decision support in cancer therapySemantic proximity Read ↗

Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and cliniciansSemantic proximity Read ↗

TMBpred: A bioinformatics tool for precise prediction of the Tumor Mutation Burden in 14 cancer typesSemantic proximity Read ↗

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsSemantic proximity Read ↗

Tumor mutational burden assessment and standardized bioinformatics approach using custom NGS panels in clinical routine.Semantic proximity Read ↗

Tumor mutational burden measurement using comprehensive genomic profiling assay.Semantic proximity Read ↗

Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologySemantic proximity Read ↗

Assessment of tumor mutation burden calculation from gene panel sequencing dataSemantic proximity Read ↗

Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumorsSemantic proximity Read ↗

Molecular profiling of solid tumors by next generation sequencing and challenges faced in the healthcare settingSemantic proximity Read ↗

High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.